FDA OKs Crizotinib for Myofibroblastic Tumors : vimarsana.co

The tyrosine kinase inhibitor has already been approved for certain patients with non-small cell lung cancer and anaplastic large cell lymphoma.

Related Keywords

, Pfizer , Drug Administration , Medscapemedical News , Watch Reporting System , Lung Cancer , Ung Carcinoma , Ancer Lung , Non Small Cell Lung Cancer , Nsclc , Drug Development , Biologic Therapy , Us Food And Drug Administration , Nited States Food And Drug Administration , Fda , Tyrosine Kinase Inhibitor , Rlotinib , Efitinib , Matinib , U11248 , Unitinib , Anaplastic Lymphoma Kinase Alk , Lk Tyrosine Kinase Receptor , D246 Cluster Of Differentiation 246 , Children , Child , Childhoo ,